Broadwood Partners, a 27.5 % shareholder of STAAR Surgical, issued a statement on October 24 2025 condemning the decision by STAAR and Alcon to postpone the shareholder vote on the proposed merger. The statement accuses the STAAR board of reneging on its promise to let shareholders decide the transaction in a timely manner and calls for the removal of key board members.
The delay moves the vote to November 6 2025, with the record date for eligible shareholders remaining September 12 2025. Broadwood is preparing a special meeting to remove the STAAR chair, CEO, and compensation committee chair, and is urging shareholders to vote against the transaction. The postponement also extends the uncertainty surrounding the merger’s completion.
This postponement of the vote is a material event for Alcon, as it delays the integration of STAAR’s assets and could affect shareholder value and the company’s strategic timeline. The announcement signals significant shareholder opposition and may impact the momentum of the Alcon‑STAAR transaction.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.